AANEM News Express

AANEM News Express

AANEM Endorses International Consensus Guidance for MG Management

11/2/2016
 
The AANEM Board of Directors has endorsed the International Consensus Guidance for the Management of Myasthenia Gravis, which was recently published in Neurology, the official journal of the American Academy of Neurology.

This endorsement is a support of the research and findings, and followed the recommendation and approval of the AANEM Professional Practice Committee, and a subsequent review by the AANEM Board of Directors.

This consensus guidance statement was developed by a task force of the Myasthenia Gravis Foundation of America (MGFA) to provide guidance to clinicians who treat patients with myasthenia gravis (MG) and to help MG patients and their families make informed decisions about their treatment. Consensus of expert opinions is used to develop such guidance statements when available studies do not provide strong information about the treatment of a condition. Using the Rand-UCLA Appropriate Method of formal consensus, the MGFA task force panel of 15 physicians from 9 countries developed guidance statements for 7 specific treatment areas, including symptomatic and immunosuppressive therapy, management of MG crisis, thymectomy and management of MG during pregnancy.  The Executive Summary and full report of the Guidance Statements are available to the public as Open Access papers and may be accessed on the AANEM website under the Practice/Guidelines and quality section at this link.


View Related News Stories:

  Practice


Recent AANEM News

Science News: A Model to Predict the Probability of Acute Inflammatory Demyelinating Polyneuropathy

AANEM Creating Neuromuscular Medicine Fellowship Application and Offer System

AANEM Joins in Support of Legislative Efforts to Protect Physician Visas

2020 Golseth Young Investigator Award Winners Announced

Submit Your 2021 AANEM Achievement Award Nominations Now





Advertisement

ABEM

Advertisement

TPP

Advertisement

Devon products